Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.35 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.35 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.34 |
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | TP53 | P04637 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10423763 | 0.99 | ALDH1A1 (0.36) | ALDH1A1PTGS2L3MBTL1CCNB2CDK1 | |
| SCHEMBL15919248 | 0.80 | CCNB2 (0.31) | CCNB2CDK1CCNB1GSK3AGSK3B | |
| SCHEMBL7261530 | 0.78 | ALDH1A1 (0.35) | ALDH1A1PTGS2L3MBTL1CCNB2CDK1 | |
| SCHEMBL3076219 | 0.77 | — | — | |
| SCHEMBL7268045 | 0.75 | — | — | |
| SCHEMBL473159 | 0.74 | MAOA (0.32) | — | |
| SCHEMBL1998705 | 0.74 | ALDH1A1 (0.35) | ALDH1A1L3MBTL1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL5576185 | 0.74 | POLB (0.40) | ALDH1A1PTGS2APPSMN1; SMN2RAB9A | |
| SCHEMBL6033614 | 0.73 | PTPN1 (0.43) | ALDH1A1L3MBTL1HSD17B10SMN1; SMN2RAB9A | |
| SCHEMBL9680172 | 0.71 | KDM4E (0.33) | ALDH1A1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5292409-A | Electrolytically generating superoxide ion under protective layer of ion exchange material | CAPE COD RESEARCH, INC. (US) | 1994-03-08 | — | — | US | claimed |
| WO-2025089409-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION DEVICE, MOBILE BODY, AND BUILDING MATERIAL | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025089411-A1 | COMPOSITION, PREPARATION METHOD FOR COMPOSITION, AND PHOTOELECTRIC CONVERSION ELEMENT | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025089384-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION DEVICE | キヤノン株式会社 | 2025-05-01 | — | — | WO | disclosed |
| CN-119530876-A | Composite catalyst, electrode carrying composite catalyst, and preparation method and application of electrode | 中国石油化工股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-111675620-A | Method for catalytic oxidation of toluene and derivatives thereof by metalloporphyrin | 浙江工业大学 | 2020-09-18 | — | — | CN | disclosed |
| CN-109301266-A | Oxygen reduction catalyst and its preparation method and application | 德州新动能铁塔发电有限公司 | 2019-02-01 | — | — | CN | disclosed |
| CN-107195935-A | CIHT dynamical systems | 辉光能源公司 | 2017-09-22 | — | — | CN | disclosed |
| CN-105111418-B | The preparation method of stereoregular polylactic acid under a kind of temperate condition | 武汉理工大学 | 2016-09-14 | — | — | CN | disclosed |
| US-20110136774-A1 | Anti-Apoptotic Benzodiazepine Receptor Ligand Inhibitors | MALFROY-CAMINE BERNARD | 2011-06-09 | — | — | US | disclosed |
| WO-2008033444-A2 | ANTI-APOPTOTIC BENZODIAZEPINE RECEPTOR LIGAND INHIBITORS | EUKARION, INC. (US) | 2008-03-20 | — | — | WO | disclosed |
| EP-1856751-A2 | PRODUCTION OF A PLATINUM-FREE CHELATE CATALYST MATERIAL AS AN INTERMEDIATE PRODUCT, AND FURTHER PROCESSING THEREOF TO OBTAIN AN ELECTROCATALYTIC COATING AS A FINAL PRODUCT | Hahn-Meitner-Institut Berlin GmbH (DE) | 2007-11-21 | — | — | EP | disclosed |
| WO-2007004045-A9 | USE OF A PHOTOSENSITIZING AGENT IN THE TREATMENT OR PREVENTION OF AN INFLAMMATION-ASSOCIATED DISORDER IN THE GASTROINTESTINAL TRACT OF A MAMMAL | UNIV LAUSANNE (CH) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007004045-A2 | USE OF A PHOTOSENSITIZING AGENT IN THE TREATMENT OR PREVENTION OF AN INFLAMMATION-ASSOCIATED DISORDER IN THE GASTROINTESTINAL TRACT OF A MAMMAL | UNIVERSITE DE LAUSANNE (CH) | 2007-01-11 | — | — | WO | disclosed |
| CN-1279907-C | Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy | BROOKHAVEN SCIENCE ASS LLC (US) | 2006-10-18 | — | — | CN | disclosed |
| WO-2006086979-A2 | PRODUCTION OF A PLATINUM-FREE CHELATE CATALYST MATERIAL AS AN INTERMEDIATE PRODUCT, AND FURTHER PROCESSING THEREOF TO OBTAIN AN ELECTROCATALYTIC COATING AS A FINAL PRODUCT | HAHN-MEITNER-INSTITUT BERLIN GMBH (DE) | 2006-08-24 | — | — | WO | disclosed |
| CN-1635654-A | Application of products with active carbon surface chemically decorated by porphyrin and phthalocyanine in fuel cells | UNIV SHANDONG TECHNOLOGY (CN) | 2005-07-06 | — | — | CN | disclosed |
| CN-1620289-A | Novel metalloporphyrin compounds and their use as radiosensitizers in radiotherapy | BROOKHAVEN SCIENCE ASS LLC (US) | 2005-05-25 | — | — | CN | disclosed |
| US-4255273-A | COMPRISING A WATER-SOLUBLE PHOTOACTIVATOR AND A CATIONIC SUBSTANCE | THE PROCTER & GAMBLE COMPANY (US) | 1981-03-10 | — | — | US | disclosed |
| EP-0003371-A1 | Composition containing a cationic substance and a photoactivator for improved washing and bleaching of fabrics | THE PROCTER & GAMBLE COMPANY (US) | 1979-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136774-A1 | Anti-Apoptotic Benzodiazepine Receptor Ligand Inhibitors | AIFM1, BAK1, BAX | ALDH1A1 2737/4885PTGS2 492/4885L3MBTL1 2476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.